Key Factors Differentiating Tolerance vs Immunosuppression to Guide Development of Precise & Antigen-Specific Therapeutic Approaches
Time: 8:30 am
day: Conference Day One
Details:
- Understanding the specificity of current tolerance approaches to benchmark against traditional immunosuppression, drawing upon tolerance definitions from the Immune
- Tolerance Network’s clinical trials in autoimmunity, allergy, and transplant
- Highlighting the role of antigen-specificity and bystander tolerance in therapeutic approaches
- Leveraging insight from the Immune Tolerance Network’s current clinical trials to induce tolerance in autoimmune diseases including multiple sclerosis, systemic sclerosis, antiphospholipid syndrome, vitiligo, and type I diabetes
